ClassID:

96740

C07K7/08 - page 12 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids

Recent Application in this class:
#3301
20140024596
2014-01-23

DISEASE INHIBITING AGENT

#3302
20140024593
2014-01-23

Treatments of gastrointestinal disorders

#3303
20140023672
2014-01-23

FOXM1 peptide and medicinal agent comprising the same

#3304
20140018307
2014-01-16

LINACLOTIDE COMPOSITIONS

#3305
20140018257
2014-01-16

Peptide library production method, peptide library, and screening method

#3306
20140011979
2014-01-09

Stitched polypeptides

#3307
20140010815
2014-01-09

Monoclonal antibody having immunosuppressive activity or antigen binding fragment thereof

#3308
20140005358
2014-01-02

Natriuretic polypeptides

#3309
20140005118
2014-01-02

Beta-catenin targeting peptides and uses thereof

#3310
20140005117
2014-01-02

COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES

#3311
20140004130
2014-01-02

MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo

#3312
20140004109
2014-01-02

Methods of reducing basophil levels

#3313
20140004040
2014-01-02

Methods and compositions for targeting sites of neovascular growth

#3314
20130345407
2013-12-26

Method of producing a positive inotropic effect using an antibody that binds sodium potassium atpase

#3315
20130345394
2013-12-26

NPR-B agonists

#3316
20130345393
2013-12-26

Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method

#3317
20130345141
2013-12-26

Method for regulating circadian rhythms

#3318
20130345138
2013-12-26

Polypeptides derived from calcitonin receptors and methods of use

#3319
20130345117
2013-12-26

Peptide-phospholipid conjugates

#3320
20130344592
2013-12-26

Factor H binding peptides and uses thereof

#3321
20130338341
2013-12-19

Peptides having antimicrobial activity

#3322
20130338340
2013-12-19

Peptides having antimicrobial activity

#3323
20130338338
2013-12-19

α-Conotoxin peptides

#3324
20130338075
2013-12-19

Methods and compositions for the treatment of axonal and neuronal degeneration

#3325
20130338063
2013-12-19

Methods and Compositions for the Treatment of Gastrointestinal Disorders

#3326
20130337085
2013-12-19

Use of ide as a biomarker for a scalp condition

#3327
20130337050
2013-12-19

Drug transporter permeating blood-brain barrier, peptide and use thereof

#3328
20130337028
2013-12-19

BIOMIMETIC PEPTIDES FOR BONE AUGMENTATION

#3329
20130337002
2013-12-19

Peptide scaffold design

#3330
20130336904
2013-12-19

Anti-ageing peptides modulating survivin and compositions including same

#3331
20130331333
2013-12-12

PAR1 and PAR2 c-tail peptides and peptide mimetics

#3332
20130330744
2013-12-12

Nitrated cardiac troponin I as a biomarker of cardiac ischemia

#3333
20130324476
2013-12-05

COSMETIC USE OF DERMICIDIN, AND ANALOGUES OR FRAGMENTS THEREOF

#3334
20130323272
2013-12-05

Powerful MHC-class II peptides derived from survivin

#3335
20130323244
2013-12-05

Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof

#3336
20130323187
2013-12-05

SYNTHETIC PEPTIDES FOR USE AS INHIBITORS OF NEUROTRANSMITTER SECRETION AND AS INDUCERS OF CELLULAR RELAXATION

#3337
20130316956
2013-11-28

NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF

#3338
20130316942
2013-11-28

Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof

#3339
20130316448
2013-11-28

PEPTIDES AND RELATED MOLECULES THAT MODULATE NERVE GROWTH FACTOR ACTIVITY

#3340
20130315920
2013-11-28

Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans

#3341
20130310313
2013-11-21

Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

#3342
20130310306
2013-11-21

Human lactoferrin derived peptides and their use

#3343
20130310303
2013-11-21

Glycogen synthase kinase-3 inhibitors

#3344
20130309693
2013-11-21

Polypeptides for microbial detection

#3345
20130309222
2013-11-21

Affinity peptides toward infliximab

#3346
20130309193
2013-11-21

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

#3347
20130303744
2013-11-14

USP2A PEPTIDES AND ANTIBODIES

#3348
20130303452
2013-11-14

Peptide analogs of alpha-melanocyte stimulating hormone

#3349
20130303441
2013-11-14

Glycogen synthase kinase-3 inhibitors

#3350
20130303439
2013-11-14

CHIMERIC PEPTIDES INCLUDING A PENETRATING PEPTIDE AND A BINDING DOMAIN OF PP2A CATALYTIC SUBUNIT TO CASPASE-9

#3351
20130302362
2013-11-14

Immunomodulatory Compositions, Methods and Systems Comprising Immunogenic Fragments of ApoB-100

#3352
20130302249
2013-11-14

Intestinal peptide targeting ligands

#3353
20130296227
2013-11-07

Antimicrobial cationic peptides and formulations thereof

#3354
20130296224
2013-11-07

METHOD FOR TREATMENT OF INFLAMMATORY DISEASE AND DISORDER

#3355
20130295123
2013-11-07

Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy

#3356
20130288980
2013-10-31

TARGETING SENESCENT AND CANCER CELLS FOR SELECTIVE KILLING BY INTERFERENCE WITH FOXO4

#3357
20130288978
2013-10-31

Dermatopontin-activating peptides and cosmetic compositions including same

#3358
20130288974
2013-10-31

Method for ameliorating pain by modification of NMDA receptors through inhibition of SRC

#3359
20130288963
2013-10-31

Anticancer fusion protein comprising trail and a growth factor receptor inhibitor

#3360
20130288961
2013-10-31

Methods for treating steatotic disease

#3361
20130287804
2013-10-31

Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide

#3362
20130281660
2013-10-24

Detection of degradative enzymes and biomolecules in bodily fluids

#3363
20130280760
2013-10-24

High purity lipopeptides

#3364
20130280281
2013-10-24

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

#3365
20130274206
2013-10-17

Compositions and methods for promoting wound healing and tissue regeneration

#3366
20130274205
2013-10-17

Peptidomimetic macrocycles

#3367
20130274204
2013-10-17

Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders

#3368
20130274202
2013-10-17

Peptides for treating cancer

#3369
20130274201
2013-10-17

Selective anticancer chimeric peptides which bind neuropilin receptor

#3370
20130274200
2013-10-17

Selective anticancer chimeric peptides which bind transferrin receptor

#3371
20130274193
2013-10-17

TFPI inhibitors and methods of use

#3372
20130274187
2013-10-17

Peptides and methods of using same

#3373
20130274181
2013-10-17

Obesity-related genes and their proteins and uses thereof

#3374
20130274178
2013-10-17

Active cores of peptide triazole HIV-1 entry inhibitors

#3375
20130274177
2013-10-17

Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof

#3376
20130273058
2013-10-17

Synthetic peptide inhibitors of Wnt pathway

#3377
20130267677
2013-10-10

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

#3378
20130266958
2013-10-10

Method for activating helper T cell

#3379
20130266663
2013-10-10

SOX9 INHIBITORS

#3380
20130266597
2013-10-10

Small cationic antimicrobial peptides

#3381
20130266592
2013-10-10

Companion animal treatments

#3382
20130266537
2013-10-10

Moesin modulators and uses thereof

#3383
20130259929
2013-10-03

USE OF A PHOSPHOPEPTIDE ABLE TO BLOCK HER3/P85 INTERACTION FOR THE TREATMENT OF HER2 HYPER-EXPRESSING TUMOURS

#3384
20130259884
2013-10-03

PEPTIDES

#3385
20130259883
2013-10-03

CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS

#3386
20130259863
2013-10-03

TFPI inhibitors and methods of use

#3387
20130252905
2013-09-26

PLIF multimeric peptides and uses thereof

#3388
20130252896
2013-09-26

TFPI inhibitors and methods of use

#3389
20130252895
2013-09-26

Peptides of syndecan-1 for inhibit angiogenesis

#3390
20130252891
2013-09-26

Therapeutically active α-MSH analogues

#3391
20130251719
2013-09-26

BONE MARROW APLASIA WITH HAEMORRHAGIC DISEASE IN CALVES CAUSED BY NOVEL PATHOGEN

#3392
20130244949
2013-09-19

Anticancer agents comprising peptides with cancer-specific toxicity

#3393
20130244947
2013-09-19

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

#3394
20130244946
2013-09-19

Compositions for treatment of neurodegenerative diseases

#3395
20130244939
2013-09-19

NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR

#3396
20130244934
2013-09-19

VIP fragments and methods of use

#3397
20130244928
2013-09-19

Antimicrobial peptides and derived metapeptides

#3398
20130244232
2013-09-19

HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF

#3399
20130243959
2013-09-19

Method for manufacturing a gold core/insulator shell nanostructure using a novel peptide

#3400
20130243804
2013-09-19

Peptide sequences and compositions

#3401
20130243802
2013-09-19

Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy

#3402
20130239238
2013-09-12

Immunoglobulin cleavage fragments and disease indicators and compositions for detecting and binding such

#3403
20130237484
2013-09-12

Cell-permeable peptide

#3404
20130236418
2013-09-12

Immunomodulatory methods and systems for treatment and/or prevention of aneurysms

#3405
20130231294
2013-09-05

TDF-related compounds and analogs thereof, analogs and bioactive fragments

#3406
20130231289
2013-09-05

Synthetic analogues of neural regeneration peptides

#3407
20130231251
2013-09-05

Methods for selective targeting

#3408
20130230591
2013-09-05

Peptide for use as a medicament, in particular for the treatment of cancer

#3409
20130230487
2013-09-05

Immunomodulatory methods and systems for treatment and/or prevention of hypertension

#3410
20130225488
2013-08-29

Antidiabetic compounds

#3411
20130225481
2013-08-29

Antimicrobial peptides

#3412
20130225478
2013-08-29

Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases

#3413
20130224880
2013-08-29

REAGENTS AND METHODS FOR DETECTING PROTEIN CROTONYLATION

#3414
20130224313
2013-08-29

Cancer therapy method

#3415
20130224285
2013-08-29

ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF

#3416
20130224231
2013-08-29

Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

#3417
20130224182
2013-08-29

BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE

#3418
20130217858
2013-08-22

Compositions and methods for modulating γ-c-cytokine activity

#3419
20130217857
2013-08-22

ErbB interface peptidomimetics and methods of use thereof

#3420
20130217634
2013-08-22

PEPTIDES ABLE TO INTERFERE WITH THE INHIBITING ACTIVITY OF MDM2/MDM4 HETERODIMER TOWARDS P53 AND USE THEREOF FOR CANCER TREATMENT

#3421
20130217613
2013-08-22

Dpy-30 binding peptides

#3422
20130217116
2013-08-22

Peptide II

#3423
20130217047
2013-08-22

Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof

#3424
20130216567
2013-08-22

Avian group D rotavirus

#3425
20130211049
2013-08-15

Immunotoxin fusion proteins and means for expression thereof

#3426
20130210750
2013-08-15

Polypeptide TF1 for inhibiting type 2 Shiga toxin activity, encoding gene for same and use thereof

#3427
20130210749
2013-08-15

PEPTIDES, CONSTRUCTS AND USES THEREFOR

#3428
20130210748
2013-08-15

METHOD AND PEPTIDE FOR REGULATING CELLULAR ACTIVITY

#3429
20130210741
2013-08-15

Immunoregulatory peptides and methods of use

#3430
20130210709
2013-08-15

CXCR4 receptor compounds

#3431
20130209541
2013-08-15

IL-13 receptor binding peptides

#3432
20130205416
2013-08-08

ANTI-VIRAL AGENT

#3433
20130203685
2013-08-08

PROTEASE TARGETING AGENTS

#3434
20130203683
2013-08-08

Immunoregulatory peptides and methods of use

#3435
20130203679
2013-08-08

Immunoregulatory peptides and methods of use

#3436
20130203649
2013-08-08

Inhibitors of TLR signaling by targeting TIR domain interfaces

#3437
20130203163
2013-08-08

Promiscuous PAP CD4 T cell epitopes

#3438
20130203060
2013-08-08

MAMMALIAN GENES; RELATED REAGENTS

#3439
20130202634
2013-08-08

Dengue Virus (DV) Polypeptide Sequences, T Cell Epitopes and Methods and Uses Thereof

#3440
20130196925
2013-08-01

Compositions and methods useful in enhancement of memory

#3441
20130196922
2013-08-01

BNIP3 ISOFORMS AND METHODS OF USE

#3442
20130196899
2013-08-01

Synthetic apelin mimetics for the treatment of heart failure

#3443
20130195909
2013-08-01

Composite antigenic sequences and vaccines

#3444
20130195860
2013-08-01

Antibody targeting through a modular recognition domain

#3445
20130193317
2013-08-01

Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry

#3446
20130190240
2013-07-25

TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1

#3447
20130190238
2013-07-25

Treatments for Gastrointestinal Disorders

#3448
20130190233
2013-07-25

Peptides, derivatives and analogs thereof, and methods of using same

#3449
20130190228
2013-07-25

Antiviral peptides against influenza virus

#3450
20130189784
2013-07-25

ANTI-HEPARAN SULFATE PEPTIDES THAT BLOCK HERPES SIMPLEX VIRUS INFECTION IN VIVO

#3451
20130189268
2013-07-25

COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES

#3452
20130184221
2013-07-18

Kinase inhibitors and uses thereof

#3453
20130184220
2013-07-18

TREATMENT OF ABNORMAL OR EXCESSIVE SCARS

#3454
20130184219
2013-07-18

Extract and peptides derived from Japonica Group and uses thereof

#3455
20130184215
2013-07-18

Peptide having a vascularization-suppressing activity and a use therefor

#3456
20130184202
2013-07-18

Peptide Inhibitors and Methods of Use Thereof

#3457
20130183237
2013-07-18

Thrombin inhibitor

#3458
20130178412
2013-07-11

DIHYDROXYPROPLY-CYSTEINE PEPTIDE AND AGENT CONTAINING THIS PEPTIDE

#3459
20130177567
2013-07-11

NOVEL C3C EPITOPE, ANTIBODIES BINDING THERETO, AND USE THEREOF

#3460
20130172530
2013-07-04

JNK inhibitor molecules

#3461
20130172272
2013-07-04

Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof

#3462
20130172265
2013-07-04

Methods and Compositions for Inhibiting Tumor Cell Proliferation

#3463
20130172258
2013-07-04

Angiogenesis-inhibiting peptide and application thereof

#3464
20130172242
2013-07-04

Growth hormone secretatogue receptor antagonists and uses thereof

#3465
20130172231
2013-07-04

Composition for treating sepsis or septic shock comprising the peptide originated from the Smad6

#3466
20130171069
2013-07-04

Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof

#3467
20130165629
2013-06-27

Bispecific T-cell activator antibody

#3468
20130164317
2013-06-27

Antimicrobial agent, bacterial strain, biosynthesis, and methods of use

#3469
20130164254
2013-06-27

Anticancer fusion protein comprising trail

#3470
20130157961
2013-06-20

Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use

#3471
20130157949
2013-06-20

Novel Peptides for Wound Healing

#3472
20130157936
2013-06-20

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

#3473
20130157928
2013-06-20

Nociceptin mimetics

#3474
20130157338
2013-06-20

RHAMM binding peptides

#3475
20130156819
2013-06-20

ISOLATION OF MESENCHYMAL STEM CELLS

#3476
20130156723
2013-06-20

Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof

#3477
20130150298
2013-06-13

Parstatin peptides

#3478
20130150297
2013-06-13

Therapeutic agents for reducing parathyroid hormone levels

#3479
20130150294
2013-06-13

Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases

#3480
20130150288
2013-06-13

TREATMENT OF VIRAL INFECTIONS

#3481
20130150260
2013-06-13

Peptide antimicrobials

#3482
20130149372
2013-06-13

Polypeptides for the treatment or prevention of cancer and uses thereof

#3483
20130149323
2013-06-13

Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties

#3484
20130149248
2013-06-13

αvβ6 peptide ligands and their uses

#3485
20130143822
2013-06-06

AGENTS FOR TREATING ALZHEIMER'S DISEASE

#3486
20130143791
2013-06-06

Peptides as active agents to stabilize biological barriers

#3487
20130142867
2013-06-06

Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis

#3488
20130137758
2013-05-30

Akt activity specifically inhibiting polypeptide

#3489
20130137603
2013-05-30

Newly identified colon cancer marker and diagnostic kit using the same

#3490
20130137106
2013-05-30

Tumor Marker and Methods of Use Thereof

#3491
20130136742
2013-05-30

PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY

#3492
20130131314
2013-05-23

Peptide derivatives for biofunctionalization of silicon substrates and their applications

#3493
20130131313
2013-05-23

EEF2K assays for identifying compounds that inhibit EEF2K activity

#3494
20130130995
2013-05-23

Treatments for gastrointestinal disorders

#3495
20130130994
2013-05-23

Antimicrobial peptides and peptide derivatives derived from

#3496
20130130989
2013-05-23

eIF4E binding peptides

#3497
20130130987
2013-05-23

Compositions for inhibiting immune complex formation in a subject

#3498
20130130976
2013-05-23

Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases

#3499
20130130970
2013-05-23

Lactadherin-derived peptides as antiviral agents

#3500
20130130268
2013-05-23

Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof

#3501
20130130233
2013-05-23

Monoclonal antibodies to human immunodeficiency virus and uses thereof

#3502
20130129764
2013-05-23

Compositions and methods to detect various infectious organisms

#3503
20130129760
2013-05-23

Telomerase polypeptide vaccine for treating cancer

#3504
20130129714
2013-05-23

Prevention and treatment of cast nephropathy

#3505
20130123466
2013-05-16

SIMULTANEOUS SYNTHESIS OF TEMPERATURE-TUNABLE PEPTIDE AND GOLD NANOPARTICLE HYBRID SPHERES

#3506
20130123460
2013-05-16

PEPTIDE FOR IMPROVING BIOSTABILITY OF BIOACTIVE SUBSTANCE, AND BIOACTIVE SUBSTANCE HAVING IMPROVED BIOSTABILITY

#3507
20130123202
2013-05-16

Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles

#3508
20130123187
2013-05-16

PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE

#3509
20130123140
2013-05-16

Identification of compounds modifying a cellular response

#3510
20130122546
2013-05-16

Signal peptide, and use thereof for producing recombinant proteins

#3511
20130122030
2013-05-16

S. EPIDERMIDIS ANTIGENS

#3512
20130116406
2013-05-09

BORRELIA ANTIGENS

#3513
20130116404
2013-05-09

TARGETED NON-INVASIVE IMAGING PROBES OF EGFR EXPRESSING CELLS

#3514
20130116184
2013-05-09

RFamide-Related Peptides and Methods Thereof

#3515
20130116168
2013-05-09

Pea protein peptides with anti activity

#3516
20130116138
2013-05-09

Peptide domains that bind small molecules of industrial significance

#3517
20130115256
2013-05-09

METHODS FOR TREATING OR PREVENTING VASCULAR GRAFT FAILURE

#3518
20130115170
2013-05-09

GM1-like peptides and uses thereof

#3519
20130109834
2013-05-02

High salt-resistance antibacterial peptide and method for producing the same

#3520
20130109619
2013-05-02

Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

#3521
20130109587
2013-05-02

USP2a peptides and antibodies

#3522
20130108614
2013-05-02

Wound healing peptides and methods of use thereof

#3523
20130108575
2013-05-02

Antibacterial and antifungal peptides

#3524
20130102758
2013-04-25

Ezrin assay method for the in vitro diagnosis of colorectal cancer

#3525
20130102757
2013-04-25

Methods for selective targeting

#3526
20130102524
2013-04-25

Compounds and their use

#3527
20130102522
2013-04-25

INHIBITORS OF PROTEIN KINASES AND USES THEREOF

#3528
20130101624
2013-04-25

LINEAR IGE PEPTIDE EPITOPES OF HAZELNUT ALLERGEN COR A 1 AND CELERY ANTIGEN API 1

#3529
20130095139
2013-04-18

Bone morphogenic protein binding peptide

#3530
20130095122
2013-04-18

Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein

#3531
20130095110
2013-04-18

Hyaluronic acid decomposition-promoting factor and inhibitor thereof

#3532
20130095092
2013-04-18

Recombinant human NaGlu protein and uses thereof

#3533
20130086701
2013-04-04

Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors

#3534
20130085261
2013-04-04

Binding partners of antibodies specific for dendritic cell antigens

#3535
20130085107
2013-04-04

Treatments for Gastrointestinal Disorders

#3536
20130084618
2013-04-04

PHENOLIC BINDING PEPTIDES

#3537
20130084303
2013-04-04

Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

#3538
20130079493
2013-03-28

Method for prepairing peptide inhibitors of a lipid-activated enzyme and peptides produced by same

#3539
20130078741
2013-03-28

IgA-binding peptide and purification of IgA using the same

#3540
20130078227
2013-03-28

Embedded chimeric peptide nucleic acids and uses thereof

#3541
20130072581
2013-03-21

Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay

#3542
20130072420
2013-03-21

Biosynthetic proline/alanine random coil polypeptides and their uses

#3543
20130071428
2013-03-21

Peptides, conjugates and method for increasing immunogenicity of a vaccine

#3544
20130071424
2013-03-21

Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein

#3545
20130071392
2013-03-21

Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia

#3546
20130065840
2013-03-14

Method and peptide for regulating cellular activity

#3547
20130065259
2013-03-14

Methods for detection of botulinum neurotoxin

#3548
20130064895
2013-03-14

Amphiphilic peptides and peptide particles

#3549
20130053544
2013-02-28

Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds

#3550
20130053327
2013-02-28

Polypeptide expressed in the stratum corneum and thereof

#3551
20130053324
2013-02-28

Self-assembling peptides and their use in the formation of hydrogels

#3552
20130053321
2013-02-28

Inhibitors of mitochondrial fission and methods of use thereof

#3553
20130052209
2013-02-28

PROTEIN DRUG FORMULATIONS AND PACKAGES

#3554
20130045922
2013-02-21

Pro-angiogenic fragments of prominin-1 and uses thereof

#3555
20130045917
2013-02-21

Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof

#3556
20130040857
2013-02-14

Mass spectrometric assays for peptides

#3557
20130035245
2013-02-07

Inorganic-binding peptides and quality control methods using them

#3558
20130023485
2013-01-24

PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS

#3559
20130023461
2013-01-24

Oligopeptide compounds and uses thereof

#3560
20130019325
2013-01-17

Light-sensitive ion-passing molecules

#3561
20130018003
2013-01-17

Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles

#3562
20130018002
2013-01-17

Compositions and methods for treating cancer by inhibiting the secretion of microparticles

#3563
20130012456
2013-01-10

Compositions and methods for transport across the blood brain barrier

#3564
20130011356
2013-01-10

HAIR-BINDING PEPTIDES

#3565
20130011335
2013-01-10

Materials related to sodium/potassium adenosine triphosphatase and Src

#3566
20130005034
2013-01-03

ARTIFICIAL PEPTIDE AND USE THEREOF

#3567
20130004456
2013-01-03

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

#3568
20130004415
2013-01-03

Joint-homing peptides and uses thereof

#3569
20120329728
2012-12-27

Compositions and methods for modulating γ-c-cytokine activity

#3570
20120328735
2012-12-27

PROCESS FOR PREPARING CASEIN-DERIVED PEPTIDES BY FERMENTATION OF LACTIC ACID BACTERIA

#3571
20120328692
2012-12-27

POTENT D-PEPTIDE ANTAGONISTS OF MDM2 AND MDMX FOR ANTICANCER THERAPY

#3572
20120322081
2012-12-20

METHODS FOR DETECTION OF BOTULINUM NEUROTOXIN

#3573
20120316118
2012-12-13

Oligopeptide improving differentiation of osteoblasts

#3574
20120316100
2012-12-13

Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism

#3575
20120315701
2012-12-13

Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same

#3576
20120309695
2012-12-06

CRYSTALLINE FORM OF LINACLOTIDE

#3577
20120309676
2012-12-06

Lantibiotic Salts

#3578
20120308638
2012-12-06

Antimicrobial peptides

#3579
20120302728
2012-11-29

Actagardine derivatives, and pharmaceutical use thereof

#3580
20120295838
2012-11-22

Selective poly-substituted glycine antibiotics and related compositions

#3581
20120295837
2012-11-22

NOVEL ANTIMICROBIAL AGENTS

#3582
20120289479
2012-11-15

Materials and methods related to sodium/potassium adenosine triphosphase and cholesterol

#3583
20120289460
2012-11-15

Method of inhibiting bile acid absorption by administering an agonist of a guanylate cyclase receptor

#3584
20120289458
2012-11-15

Treatment of influenza virus infection

#3585
20120283415
2012-11-08

Multivalent Antibodies

#3586
20120283410
2012-11-08

ATTACHMENT OF BIOLOGICAL TARGETING GROUPS USING METAL FREE CLICK CHEMISTRY

#3587
20120283196
2012-11-08

β-hairpin peptidomimetics

#3588
20120283194
2012-11-08

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

#3589
20120283168
2012-11-08

Template-fixed peptidomimetics with CCR10 antagonistic activity

#3590
20120277166
2012-11-01

CONOTOXIN PEPTIDES USEFUL AS INHIBITORS OF NEURONAL AMINE TRANSPORTERS

#3591
20120277160
2012-11-01

Composition for improving brain function and method for improving brain function

#3592
20120269843
2012-10-25

S. epidermidis antigens

#3593
20120269815
2012-10-25

NEUROTROPHINS AND USES THEREOF

#3594
20120264912
2012-10-18

Self-assembling peptide amphiphiles and related methods for growth factor delivery

#3595
20120258921
2012-10-11

Peptides for the treatment of hearing

#3596
20120258920
2012-10-11

Peptides and aptamers thereof as specific modulators of mutant p53 function

#3597
20120258891
2012-10-11

DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS

#3598
20120253009
2012-10-04

THROMBOPOIETIC COMPOUNDS

#3599
20120252734
2012-10-04

Inhibitors of antigen presentation by MHC class II molecules

#3600
20120245338
2012-09-27

Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same